• Intellia Therapeutics awarded three new employees time-based restricted stock units covering 12,900 common shares on Nov. 1, 2026.
• One-third of the RSUs vest annually over three years, subject to continued employment or other service through each vesting date.
• The awards were granted under the amended 2024 Inducement Plan, outside stockholder-approved equity incentive plans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061605PRIMZONEFULLFEED9872502) on November 06, 2026, and is solely responsible for the information contained therein.